GoodRx Holdings (GDRX) Other Accumulated Expenses (2019 - 2023)

GoodRx Holdings has disclosed Other Accumulated Expenses across 5 years of filings, most recently posting $8.5 million for Q1 2023.

• In Q1 2023, Other Accumulated Expenses rose 77.36% year-over-year to $8.5 million; the TTM figure through Mar 2023 stood at $8.5 million (up 77.36% YoY), while the FY2022 annual figure was $6.9 million, up 58.98% from the prior year.
• Other Accumulated Expenses came in at $8.5 million for Q1 2023 at GoodRx Holdings, up from $6.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $11.4 million in Q3 2022 to a low of $1.9 million in Q4 2019.
• Average Other Accumulated Expenses over 5 years is $5.9 million, with a median of $5.2 million recorded in 2021.
• Year-over-year, Other Accumulated Expenses jumped 278.91% in 2020 and tumbled 39.64% in 2021.
• Over 5 years, Other Accumulated Expenses stood at $1.9 million in 2019, then jumped by 278.91% to $7.2 million in 2020, then plunged by 39.64% to $4.3 million in 2021, then surged by 58.98% to $6.9 million in 2022, then increased by 23.44% to $8.5 million in 2023.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $8.5 million in Q1 2023, $6.9 million in Q4 2022, and $11.4 million in Q3 2022.